StonvexLoading…
StonvexStonvexStonvexCore line items from NICE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.95B | $2.74B | $2.38B | $2.18B |
Operating Income | $645.76M | $545.95M | $435.23M | $335.17M |
Net Income | $612.10M | $439.50M | $336.50M | $265.10M |
EPS (Diluted) | $9.67 | $6.76 | $5.11 | $4.00 |
Total Assets | $5.11B | $5.30B | $5.12B | $4.85B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $379.39M | $481.71M | $511.80M | $529.60M |
Free Cash Flow OCF − CapEx | $697.63M | $797.68M | $532.23M | $447.82M |
Shares Outstanding | 60.43M | 63.25M | 62.87M | 63.63M |